Antibodies for COVID-19
Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of COVID-19, several of which were validated using virus-infected cell lysates.
Explore the collections of COVID-19 Antibodies, Detection Kits.
IL36RN
State-of-the art technologies helping to deliver guaranteed Fab, scFv, bi-specific, tribodies, humanized antibodies, and more.
Loading...
IL36RN
The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine was shown to specifically inhibit the activation of NF-kappaB induced by interleukin 1 family, member 6 (IL1F6). This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. Two alternatively spliced transcript variants encoding the same protein have been reported. [provided by RefSeq, Jul 2008]
Anti-Human IL36RN Therapeutic Antibody (TAB-430CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
Recombinant Mouse anti-Human IL36RN Monoclonal antibody (NN0495-3K40) (MOB-0237CT)
-
- Species Reactivity: Human
- Application: WB
Afuco™ Anti-Human IL36RN ADCC Therapeutic Antibody, ADCC Enhanced (AFC-413CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
© 2007 - 2020 Creative BioLabs All Rights Reserved